Holen Sie sich die Stockscreener-App
6.63
3.59%
0.23
Handel nachbörslich:
6.60
-0.03
-0.45%
Schlusskurs vom Vortag:
$6.40
Offen:
$6.41
24-Stunden-Volumen:
19,685
Relative Volume:
0.34
Marktkapitalisierung:
$29.90M
Einnahmen:
$86.55M
Nettoeinkommen (Verlust:
$-56.70M
KGV:
-2.5785
EPS:
-2.5713
Netto-Cashflow:
$4.87M
1W Leistung:
+2.79%
1M Leistung:
+27.50%
6M Leistung:
+12.62%
1J Leistung:
+100.97%
1-Tages-Spanne:
$6.41
$6.75
1-Wochen-Bereich:
$6.0488
$6.75
52-Wochen-Spanne:
$2.813
$9.458
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
6.63 | 28.87M | 86.55M | -56.70M | 4.87M | -2.5713 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Eingeleitet | Northland Capital | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Herabstufung | Janney | Buy → Neutral |
| 2018-01-24 | Bestätigt | Janney | Buy |
| 2018-01-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-11-17 | Eingeleitet | Singular Research | Buy |
| 2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
Before the bell: Harvard Bioscience posts Q1 results May 12 - Stock Titan
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET - Sahm
HBIO Harvard Bioscience Inc. posts 100 percent Q4 2025 EPS miss vs estimates, shares rise 3.72 percent in today's trading.Most Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Harvard Bioscience (HBIO) Quarterly Preview | Q4 2025: Below ExpectationsOpen Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Harvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
HBIO Stock Price, Quote & Chart | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill
Harvard Bioscience (HBIO) price target increased by 200.00% to 6.12 - MSN
Will Harvard Bioscience Inc outperform tech stocks2026 Key Lessons & Community Verified Swing Trade Signals - baoquankhu1.vn
Options Flow: Whats the fair value of Harvard Bioscience Inc stockPortfolio Risk Summary & Capital Efficient Trade Techniques - baoquankhu1.vn
Profit Recap: What are analysts price targets for Harvard Bioscience IncPrice Action & Low Volatility Stock Suggestions - baoquankhu1.vn
HBIO | Harvard Bioscience Inc Insider Trading - Quiver Quantitative
Published on: 2026-04-06 23:13:26 - baoquankhu1.vn
Setup Watch: Will Harvard Bioscience Inc face regulatory challengesWeekly Stock Recap & Community Shared Stock Ideas - baoquankhu1.vn
Harvard Bioscience CFO Frost buys $25,000 in HBIO stock By Investing.com - Investing.com Australia
Harvard Bioscience CFO Frost buys $25,000 in HBIO stock - Investing.com
Harvard Bioscience (NASDAQ: HBIO) CFO awarded 30,000 RSUs in equity grant - Stock Titan
Harvard Bioscience (HBIO) CFO adds 5,000 shares at $5.00 - Stock Titan
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN
Is Harvard Bioscience Inc stock a top performer YTD2026 Growth vs Value & Reliable Entry Point Alerts - baoquankhu1.vn
Debt to assets ratio of Harvard Bioscience, Inc. – MUN:HBI0 - TradingView
Trading Recap: Is Harvard Bioscience Inc forming a bullish divergenceWeekly Investment Summary & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
EBIT of Harvard Bioscience, Inc. – MUN:HBI0 - TradingView
Harvard Bioscience, Inc. (HBIO) Stock forecasts - Yahoo Finance UK
HARVARD BIOSCIENCE (NASDAQ: HBIO) CEO receives 75,000-share stock grant - Stock Titan
William Snider Secures Board Seat at Harvard Bioscience with 15.97% Stake - TradingView
BroadOak reports 16% Harvard Bioscience (HBIO) stake tied to loans and warrants - Stock Titan
Harvard Bioscience stock faces scrutiny amid Q4 earnings anticipation and life sciences sector volat - AD HOC NEWS
Taxes of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience Outlines Post-Refi Strategy, Organoid Growth Focus - National Today
Total equity of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LS:A423J5 - TradingView
Free cash flow per share of Harvard Bioscience, Inc. – FWB:HBI0 - TradingView
Equity in earnings of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Equity in earnings of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Cash per share of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Harvard Bioscience, Inc. Cash Flow – GETTEX:HBI0 - TradingView
Net income of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Price to earnings ratio of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Net debt of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Return on assets % of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Total revenue of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LSX:A423J5 - TradingView
Insider Buying: Stephen Denelsky Acquires 10,000 Shares of Harva - GuruFocus
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares By Investing.com - Investing.com India
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares - Investing.com
Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares - MarketBeat
Harvard Bioscience (HBIO) director buys 10,000 shares in open market - Stock Titan
Harvard Bioscience director Snider buys $103,603 in HBIO stock By Investing.com - Investing.com Australia
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares - MarketBeat
Harvard Bioscience director Snider buys $103,603 in HBIO stock - Investing.com
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):